Resveratrol inhibits drug-induced apoptosis in human leukemia cells by creating an intracellular milieu nonpermissive for death execution.
D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D003630:Daunorubicin / Q000494:pharmacology; D018922:HL-60 Cells; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007938:Leukemia / Q000188:drug therapy* / Q000473:pathology; D008928:Mitochondria / Q000502:physiology; D019255:NADPH Oxidases / Q000378:metabolism; D010084:Oxidation-Reduction; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology*; D013481:Superoxides / Q000378:metabolism; D014750:Vincristine / Q000494:pharmacology
D000972:Antineoplastic Agents, Phytogenic; D013267:Stilbenes; D013481:Superoxides; D014750:Vincristine; D006861:Hydrogen Peroxide; D019255:NADPH Oxidases; D000077185:Resveratrol; D003630:Daunorubicin